Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury.

Wojakowski W, Tendera M, Cybulski W, Zuba-Surma EK, Szade K, Florczyk U, Kozakowska M, Szymula A, Krzych L, Paslawska U, Paslawski R, Milewski K, Buszman PP, Nabialek E, Kuczmik W, Janiszewski A, Dziegiel P, Buszman PE, Józkowicz A, Dulak J.

Thromb Haemost. 2012 Sep;108(3):464-75. doi: 10.1160/TH12-05-0303. Epub 2012 Aug 7.

PMID:
22872040
2.

Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.

Yao K, Huang R, Qian J, Cui J, Ge L, Li Y, Zhang F, Shi H, Huang D, Zhang S, Sun A, Zou Y, Ge J.

Heart. 2008 Sep;94(9):1147-53. doi: 10.1136/hrt.2007.137919. Epub 2008 Apr 1.

PMID:
18381377
3.

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.

Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD; Cardiovascular Cell Therapy ResearchNetwork.

JAMA. 2011 Nov 16;306(19):2110-9. doi: 10.1001/jama.2011.1670. Epub 2011 Nov 14.

4.

Long-term tracking of bone marrow progenitor cells following intracoronary injection post-myocardial infarction in swine using MRI.

Graham JJ, Foltz WD, Vaags AK, Ward MR, Yang Y, Connelly KA, Vijayaraghavan R, Detsky JS, Hough MR, Stewart DJ, Wright GA, Dick AJ.

Am J Physiol Heart Circ Physiol. 2010 Jul;299(1):H125-33. doi: 10.1152/ajpheart.01260.2008. Epub 2010 Apr 23.

5.

Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.

Delewi R, Hirsch A, Tijssen JG, Schächinger V, Wojakowski W, Roncalli J, Aakhus S, Erbs S, Assmus B, Tendera M, Goekmen Turan R, Corti R, Henry T, Lemarchand P, Lunde K, Cao F, Huikuri HV, Sürder D, Simari RD, Janssens S, Wollert KC, Plewka M, Grajek S, Traverse JH, Zijlstra F, Piek JJ.

Eur Heart J. 2014 Apr;35(15):989-98. doi: 10.1093/eurheartj/eht372. Epub 2013 Sep 11. Review.

6.

Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival.

Spiegelstein D, Kim C, Zhang Y, Li G, Weisel RD, Li RK, Yau TM.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3311-6. Epub 2007 Sep 7.

7.

2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.

Hwa JS, Jin YC, Lee YS, Ko YS, Kim YM, Shi LY, Kim HJ, Lee JH, Ngoc TM, Bae KH, Kim YS, Chang KC.

J Ethnopharmacol. 2012 Jan 31;139(2):605-15. doi: 10.1016/j.jep.2011.12.001. Epub 2011 Dec 9.

PMID:
22179023
8.

The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction.

Yousef M, Schannwell CM, Köstering M, Zeus T, Brehm M, Strauer BE.

J Am Coll Cardiol. 2009 Jun 16;53(24):2262-9. doi: 10.1016/j.jacc.2009.02.051.

9.

Effects of Intracoronary Infusion of Escalating Doses of Cardiac Stem Cells in Rats With Acute Myocardial Infarction.

Tang XL, Rokosh G, Sanganalmath SK, Tokita Y, Keith MC, Shirk G, Stowers H, Hunt GN, Wu W, Dawn B, Bolli R.

Circ Heart Fail. 2015 Jul;8(4):757-65. doi: 10.1161/CIRCHEARTFAILURE.115.002210. Epub 2015 May 20.

10.

Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial.

Hu X, Huang X, Yang Q, Wang L, Sun J, Zhan H, Lin J, Pu Z, Jiang J, Sun Y, Xiang M, Liu X, Xie X, Yu X, Chen Z, Tse HF, Zhang J, Wang J.

Int J Cardiol. 2015 Apr 1;184:446-51. doi: 10.1016/j.ijcard.2015.02.084. Epub 2015 Feb 25.

12.

Maximizing ventricular function with multimodal cell-based gene therapy.

Yau TM, Kim C, Li G, Zhang Y, Weisel RD, Li RK.

Circulation. 2005 Aug 30;112(9 Suppl):I123-8.

13.
14.

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H.

Circulation. 2006 Mar 14;113(10):1287-94. Epub 2006 Mar 6.

15.

Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.

Kanazawa H, Tseliou E, Dawkins JF, De Couto G, Gallet R, Malliaras K, Yee K, Kreke M, Valle I, Smith RR, Middleton RC, Ho CS, Dharmakumar R, Li D, Makkar RR, Fukuda K, Marbán L, Marbán E.

J Am Heart Assoc. 2016 Feb 8;5(2). pii: e002796. doi: 10.1161/JAHA.115.002796.

16.

Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.

Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM.

Circulation. 2013 Jan 15;127(2):213-23. doi: 10.1161/CIRCULATIONAHA.112.131110. Epub 2012 Dec 5.

17.

Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene.

Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, Dzau VJ.

Circulation. 2002 Feb 5;105(5):602-7.

18.

Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.

Bhindi R, Fahmy RG, McMahon AC, Khachigian LM, Lowe HC.

J Pathol. 2012 Jun;227(2):157-64. doi: 10.1002/path.2991. Epub 2012 Feb 17.

PMID:
22344601
19.

Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion.

Gyöngyösi M, Posa A, Pavo N, Hemetsberger R, Kvakan H, Steiner-Böker S, Petrási Z, Manczur F, Pavo IJ, Edes IF, Wojta J, Glogar D, Huber K.

Thromb Haemost. 2010 Aug;104(2):376-84. doi: 10.1160/TH09-08-0558. Epub 2010 Mar 29.

PMID:
20352158
20.

Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Schächinger V, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM; REPAIR-AMI Investigators.

N Engl J Med. 2006 Sep 21;355(12):1210-21.

Supplemental Content

Support Center